InsidersTradesSigma
Sinopharm Tech Holdings Ltd.: management transactions · Hong Kong · HKEX
HKEX:sinopharm-tech-holdings-ltdHK·HKEXMcap 162M€Technology
Browse the full insider trade history of Sinopharm Tech Holdings Ltd., a listed equity based in Hong Kong. Shares are quoted on HK HK, under the supervision of HKEX. Operating in the Technology sector, Sinopharm Tech Holdings Ltd. has recorded 4 insider filings. Market capitalisation: €161.6m. The latest transaction was filed on 5 May 2026 — Purchase. Among the most active insiders: HEUNG Pik Lun. All data is accessible without an account.
4
Insider Decl.
0
Thresholds
€6,097
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended June 2024 · cache
0.26 €
Analyst consensus
Income statement
Revenue41.3 M€
Gross profit5.0 M€12% margin
Net income−19.7 M€1.4% margin
Valuation
PER (trailing)25.5x
Beta1.70
Balance sheet & cash
Market cap161.6 M€
Total debt73.3 M€
Free Cash Flow−12.6 M€
Profitability & ownership
ROA-10.4%
% insiders75.1%
% institutions0.0%
Last declaration on 5 May 2026
Declarations4 total
Executives●Purchase6HKEX
€1,69860,000 shares@ €0.02830.0011% mcap27.8% of flow
ShareXHKG
HKEX:DA20260504E00670·
Ideal exit: 25 Jan 2027 (T+270)
Executives●Purchase5HKEX
€1,31150,000 shares@ €0.02620.0008% mcap21.5% of flow
ShareXHKG
HKEX:DA20260425E00001·
Ideal exit: 18 Jan 2027 (T+270)
Executives●Purchase6HKEX
€1,59360,000 shares@ €0.02650.0010% mcap26.1% of flow
ShareXHKG
HKEX:DA20260421E00650·
Ideal exit: 15 Jan 2027 (T+270)
Executives●Purchase5HKEX
€1,49550,000 shares@ €0.02990.0009% mcap24.5% of flow
ShareXHKG
HKEX:DA20260330E00490·
Ideal exit: 22 Dec 2026 (T+270)
4 of 4 declarations